Sonography Evaluation of Amniotic Fluid

Amniotic fluid is critical during pregnancy to provide a protective and nourishing environment for the developing fetus. It maintains a sterile space, regulates temperature, and cushions against external shocks. Amniotic fluid facilitates fetal movement, essential for musculoskeletal development, and supports the growth of organs, primarily the lungs. The amount of amniotic fluid gradually increases until approximately 34 weeks gestation, after which it slightly decreases until 40 weeks and then declines more sharply after 42 weeks.  In the early stages of pregnancy, the composition of amniotic fluid resembles a complex dialysate derived from maternal serum. As the fetus grows, changes occur in the fluid's composition; notably, sodium concentration and osmolality decrease while urea, creatinine, and uric acid levels increase. Amniotic fluid also contains various steroid and protein hormones. Initially, it has little to no particulate matter, but by 16 weeks gestation, a significant number of cells shed from the amnion, skin, and tracheobronchial tree are present. These cells are crucial for antenatal diagnosis and serve as a source of DNA for karyotype analysis following amniocentesis. Typically, fetuses do not defecate during pregnancy; however, if under severe stress, they may pass meconium. This material contains bile pigments that can stain the amniotic fluid green, indicating fetal stress. The regulation of amniotic fluid volume (AFV) involves 3 primary mechanisms: placental control of water and solute transfer, fetal contributions through urine production and swallowing, and maternal factors affecting fluid balance. Before 16 weeks of gestation, amniotic fluid is maintained primarily through intramembranous flow, transitioning to fetal urine production as the kidneys mature. The evaluation of amniotic fluid can be an indicator of fetal well-being. Maternal and placental factors, including serum osmolality, blood pressure, and placental vascularity, also influence AFV by modulating intramembranous flow. Conditions like maternal dehydration or altered placental function can disrupt this balance, leading to changes in amniotic fluid levels. Clinical assessment of AF is essential to detect oligohydramnios or polyhydramnios, which can signal underlying fetal or maternal conditions. Ultrasound offers a rapid, noninvasive way to evaluate amniotic fluid. Some studies have noted that sonographic assessment of amniotic fluid may not be accurate compared to the more direct dye dilution method, as ultrasound measurements are less accurate in evaluating abnormal amniotic fluid volumes than normal volumes. However, ultrasound offers a safe real-time option with comparable clinical outcomes. Sonographic assessment can be qualitative, visually assessing the volume ratio of amniotic fluid to the fetus and placenta, or semiquantitative. The 2 main methods for semiquantitative evaluation are the deepest vertical pocket (DVP) and the amniotic fluid index (AFI). Current guidelines recommend using DVP to diagnose oligohydramnios and AFI for polyhydramnios in singleton pregnancies, as studies indicate that these methods reduce the risk of overdiagnosis. For twin pregnancies, DVP is measured separately for each sac. Therefore, a thorough understanding of amniotic fluid production, regulation, and assessment is crucial for optimizing maternal-fetal care, as abnormalities in AFV can have significant implications for perinatal outcomes.